Crinetics Pharmaceuticals... (CRNX)
NASDAQ: CRNX
· Real-Time Price · USD
29.45
-0.29 (-0.98%)
At close: Aug 19, 2025, 3:59 PM
31.00
5.26%
After-hours: Aug 19, 2025, 06:39 PM EDT
Crinetics Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.39M | 760K | 1.04M | 1.04M | 1.39M | 1.97M | 4.01M | 4.72M | 4.83M | 4.29M | 4.74M | 5.11M | 4.65M | 4.21M | 1.08M | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 2.96M | 2.75M | 3.22M | 2.26M | 1.76M | 1.41M | 1.33M | 1.46M | 1.53M | 1.45M | 1.39M | 2.08M | 2.05M | 2.04M | 2.01M | 17.77M | 31.15M | 43.44M |
Gross Profit | -149K | -58.17M | -59M | -59.45M | -58.61M | -73K | 2.68M | 3.27M | 3.3M | 2.83M | 3.35M | 3.03M | 2.6M | 2.17M | -934.92K | -17.77M | -31.15M | -43.44M |
Operating Income | -423.06M | -376.73M | -338.85M | -306.77M | -277.95M | -248.16M | -222.61M | -207.51M | -191.98M | -182.03M | -167.88M | -151.21M | -135.57M | -118.61M | -107.7M | -98.61M | -89.25M | -80.09M |
Interest Income | 53.66M | 48.95M | 41.44M | 33.79M | 25.35M | 18.72M | 13.44M | 8.62M | 7.55M | 6.16M | 4.32M | 2.49M | 1.02M | 320K | 157K | 130K | 228K | 465K |
Pretax Income | -369.83M | -328.25M | -298.41M | -277.91M | -258.54M | -235.46M | -214.53M | -199.42M | -183.89M | -175.29M | -163.92M | -149.72M | -135.65M | -119.37M | -107.64M | -98.49M | -88.96M | -79.35M |
Net Income | -369.83M | -328.25M | -298.41M | -277.91M | -258.54M | -235.46M | -212.55M | -194.88M | -177.81M | -168.54M | -159.95M | -148.32M | -135.78M | -120.17M | -107.64M | -98.49M | -88.96M | -79.35M |
Selling & General & Admin | 139.44M | 114.44M | 99.74M | 88.64M | 78.23M | 66.73M | 58.09M | 52.29M | 48.73M | 45.88M | 42.39M | 38.48M | 32.78M | 27.9M | 24.52M | 22.12M | 20.65M | 19.37M |
Research & Development | 285.01M | 263.06M | 239.68M | 218.43M | 200.37M | 182.66M | 168.26M | 159.94M | 148.09M | 140.44M | 130.22M | 117.84M | 107.43M | 94.92M | 84.25M | 76.48M | 68.6M | 60.72M |
Other Expenses | -788K | -59.13M | -59.13M | -58.34M | -58.34M | -91K | -91K | -91K | -62K | -52K | -35K | 59K | -38K | 14K | -16K | 40K | 117K | 324K |
Operating Expenses | 423.66M | 318.36M | 280.29M | 248.73M | 220.25M | 249.4M | 226.36M | 212.23M | 196.82M | 186.32M | 172.62M | 156.32M | 140.22M | 122.82M | 108.78M | 98.61M | 89.25M | 80.09M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 424.45M | 377.49M | 339.89M | 307.81M | 279.33M | 250.13M | 226.62M | 212.23M | 196.82M | 186.32M | 172.62M | 156.32M | 140.22M | 122.82M | 108.78M | 98.61M | 89.25M | 80.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | -273K | -273K | -2.26M | -4.82M | -6.08M | -6.75M | -3.96M | -1.4M | 106K | 753K | -77K | -77K | -175K | -152K |
Shares Outstanding (Basic) | 93.79M | 93.1M | 91.49M | 80.09M | 79.01M | 72.29M | 67.15M | 56.81M | 54.27M | 53.91M | 53.84M | 53.77M | 52.52M | 47.43M | 45.23M | 38.31M | 37.06M | 33.01M |
Shares Outstanding (Diluted) | 93.79M | 93.1M | 91.49M | 80.09M | 79.01M | 72.29M | 67.15M | 56.81M | 54.27M | 53.91M | 53.84M | 53.77M | 52.52M | 47.71M | 45.23M | 38.31M | 37.06M | 33.01M |
EPS (Basic) | -4.11 | -3.82 | -3.71 | -3.72 | -3.77 | -3.77 | -3.66 | -3.56 | -3.3 | -3.15 | -3.08 | -2.97 | -2.95 | -2.86 | -2.8 | -2.78 | -2.61 | -2.44 |
EPS (Diluted) | -4.11 | -3.82 | -3.71 | -3.72 | -3.77 | -3.77 | -3.66 | -3.56 | -3.3 | -3.15 | -3.07 | -2.96 | -2.94 | -2.85 | -2.8 | -2.78 | -2.61 | -2.44 |
EBITDA | -420.58M | -373.49M | -336.07M | -304.51M | -276.19M | -246.87M | -221.51M | -206.39M | -190.89M | -181.01M | -166.9M | -150.28M | -134.64M | -117.67M | -106.78M | -97.69M | -88.33M | -79.15M |
EBIT | -409.58M | -376.73M | -338.85M | -306.77M | -277.95M | -248.16M | -222.61M | -207.51M | -191.98M | -182.03M | -167.88M | -151.21M | -135.57M | -118.61M | -107.7M | -98.61M | -89.25M | -80.09M |
Depreciation & Amortization | 3.44M | 3.24M | 2.79M | 2.26M | 1.76M | 1.41M | 1.33M | 1.46M | 1.53M | 1.45M | 1.39M | 1.33M | 1.29M | 1.29M | 1.26M | 1.16M | 1.09M | 1.02M |